LexaGene, US Army to Test Automated Pathogen Detection System for Biothreats
GenomeWeb picked up our announcement and reports on LexaGene’s cooperative research agreement with the US Army: MiQLab is an RT-PCR sample-to-answer system developed for veterinary diagnostic and food safety applications. Amid the COVID-19 pandemic, LexaGene has also been exploring its use for the detection of SARS-CoV-2 and other human pathogens. Under the terms of their Cooperative…
LexaGene to Present at the SNN Network Summer Virtual Event
Dr. Jack Regan, our Founder and CEO, will present at this year’s SNN Network Summer Virtual Event on Thursday, August 19th . In addition to taking live questions from investors, Dr. Regan will be available for 1-on-1 meetings during the event. “Since launching MiQLab™, we’ve experienced a tremendous amount of growth and positive momentum resulting…
Dr. Regan with Stock News Now
Dr. Jack Regan discusses scaling MiQLab production and preparing for SNN Network’s Summer Virtual Event, the premier event in MicroCap Finance, with Stock News Now’s CEO Robert Kraft. Hear the latest on what’s happening with LexaGene as it prepares for its conferences and tradeshow exhibitions: SNN’s Summer Virtual Event is on August 17-19, 2021.
Spending on Pets Doubles to $103.6 Billion, Boosting Associated Industries
On TMCnet, analysis of how the rapid growth of pet care and veterinary costs is driving a strong market response from biotech companies: As the animal healthcare industry continues to boom, experts foresee growth like never before. It is expected that the market value will reach numbers twice as high than its current value in…
LexaGene Talking to Major Players in Plague Detection
CEO Dr. Jack Regan joined Steve Darling from Proactive Investors to share news the company will be approaching Government and showing the effectiveness and speed of their MiQLab in detecting plague.
Read Dr Jack Regan on Pandemic Prevention with Better Diagnostics
Writing in Clinical Lab Products Magazine, Dr Jack Regan makes a strong case that diagnostic technology investment is key to preventing future pandemic diseases: Diagnostics is an area that has been largely underfunded, despite the repeated and consistent warnings from virologists, microbiologists, epidemiologists, and other public health stakeholders. Years of underfunding diagnostics and inadequate testing…
Proactive Investors on MiQLab Sale to Alpine Veterinary Hospital
Check out Proactive Investors’ coverage of LexaGene’s contract with Alpine Veterinary Hospital – and Dr Regan’s upcoming conference appearances:
LexaGene’s MiQLab to be a Game Changer for Veterinary Care
LexaGene’s MiQLab to be a Game Changer for Veterinary Care: Read article by Benzinga describing how LexaGene has built MiQLab, a new molecular diagnostics analyzer that can do in-clinic veterinary diagnostic testing at the point-of-care.
BioWorld Covergage LexaGene
LexaGene covered in BioWorld on the MiQLab’s ability to detect new variants of pathogens at point-of-care. Read more.
Rapid POC Diagnostics in Vet Medicine
Dr. Sam Stewart, DVM from Ethos, describes the benefits of rapid POC diagnostics in veterinary medicine. Ethos will implement LexaGene‘s MiQLab to help deliver innovative evidence-based patient care. The article is from fall IVC Journal vol. 10 issue 4. Read now.
BioSpace Coverage on LexaGene EUA Studies
Read BioSpace’s recent coverage of LexaGene’s plans to submit for FDA Emergency Use Authorization, and how the MiQLab™ system is ideally suited to test for COVID-19 variants at point-of-care. More.
Outbreak News Today coverage of EUA plans
LexaGene was recently covered by Outbreak News Today on the news that LexaGene will begin in-house testing for variants of COVID-19. Read the story here.